ChAdOx1 nCoV-19 vaccine induces immune response and is safe in humans, early trial data suggests
The University of Oxford’s ChAdOx1 nCoV-19 vaccine induces a strong immune response with no serious adverse reactions, preliminary findings of a phase I/II trial published in The Lancet have suggested.…